Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Osteoporosis symbols : Amgn save search
Global Postmenopausal Osteoporosis Treatment Market 2023-2030: Asia-Pacific Showing Strong Growth Potential
Published: 2023-08-22 (Crawled : 22:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.56%
H: 0.1%
C: -0.32%
LLY | News | $732.2 -1.81% -0.84% 1.7M
|
Health Technology
|
| O: 0.55%
H: 0.12%
C: -0.6%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: 0.73%
H: 0.13%
C: -0.82%
osteoporosis treatment global potential growth market
Entera Bio Announces FDA’s Acceptance of a Type D Meeting Review to Affirm Design of the Pivotal, Phase 3 Protocol for EB613 PTH Mini Tablets, as the First Oral Osteoanabolic Treatment of Post-Menopausal Osteoporosis
Published: 2023-02-15 (Crawled : 15:20) - globenewswire.com
ENTX | $2.07 -6.76% -7.25% 1.2K
|
Health Technology
|
| O: 2.34%
H: 9.2%
C: 8.45%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: -0.34%
H: 0.14%
C: -0.06%
eb613 treatment meeting review osteoporosis
Global Osteoporosis Drugs Market Report 2022: Anabolic Drug Developments Show High Potential to Reshape Sector
Published: 2022-11-07 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170
|
Health Technology
|
| O: -3.13%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% 1.25% 1.6M
|
Health Technology
|
| O: -3.09%
H: 0.72%
C: -0.09%
LLY | News | $732.2 -1.81% -0.84% 1.7M
|
Health Technology
|
| O: 0.17%
H: 2.51%
C: 1.97%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: -0.33%
H: 3.48%
C: 3.31%
drug global report potential market osteoporosis
Entera Bio Announces FDA Agreement for a Single Phase 3 Clinical Trial to Support an NDA for EB613 for the Treatment of Osteoporosis
Published: 2022-10-06 (Crawled : 12:00) - globenewswire.com
ENTX | $2.07 -6.76% -7.25% 1.2K
|
Health Technology
|
| O: 7.62%
H: 0.0%
C: -7.08%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: -0.56%
H: 0.27%
C: -0.68%
eb613 treatment fda trial agreement osteoporosis
Entera Bio Hosting Key Opinion Leader Webinar on the Treatment Landscape for Osteoporosis and EB613’s Potential Impact on Wednesday, September 28th @ 10am ET
Published: 2022-09-21 (Crawled : 13:00) - biospace.com/
ENTX | $2.07 -6.76% -7.25% 1.2K
|
Health Technology
|
| O: 0.0%
H: 7.73%
C: 6.61%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: 0.62%
H: 0.65%
C: -2.04%
eb613 treatment impact potential osteoporosis
Entera Bio Presents Dose Proportional Absorption and Correlation to BMD Clinical Response Data from its Phase 2 Study of EB613 in Post-Menopausal Osteoporosis Patients at the ASBMR 2022 Annual Meeting
Published: 2022-09-12 (Crawled : 11:00) - globenewswire.com
ENTX | $2.07 -6.76% -7.25% 1.2K
|
Health Technology
|
| O: 0.72%
H: 6.43%
C: 0.0%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: -3.91%
H: 1.55%
C: -0.16%
eb613 correlation meeting response study osteoporosis
Global Osteoporosis Treatment Market to Surpass US$ 18.92 Billion by 2030 - Coherent Market Insights
Published: 2022-07-12 (Crawled : 18:00) - prnewswire.com
VTRS | News A | $11.55 1.67% 1.65% 4.4M
|
Health Technology
|
| O: -0.4%
H: 3.2%
C: 2.1%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: -0.13%
H: 0.14%
C: -0.52%
LLY | News | $732.2 -1.81% -0.84% 1.7M
|
Health Technology
|
| O: -0.32%
H: 0.6%
C: -1.94%
NNOX | News | $9.09 -2.36% -2.25% 590K
|
Health Technology
|
| O: -0.5%
H: 5.47%
C: 3.62%
LGND | $71.0 1.59% 1.38% 110K
|
Health Technology
|
| O: -0.3%
H: 3.16%
C: 2.67%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: 0.0%
H: 0.93%
C: -0.33%
treatment market osteoporosis
Osteoporosis Drugs Market - 38% of Growth to Originate from North America |Antiresorptive Drugs Segment to be Significant for Revenue Generation | 17000+ Technavio Reports
Published: 2022-01-18 (Crawled : 17:00) - prnewswire.com
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
|
| O: -1.96%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: -1.05%
H: 0.0%
C: 0.0%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: 1.4%
H: 0.0%
C: 0.0%
america drug report growth osteoporosis
Entera Bio Selected for Late Breaking Oral Presentation of Phase 2 6-Month Osteoporosis Data at ASBMR 2021 Annual Meeting
Published: 2021-09-01 (Crawled : 13:00) - globenewswire.com
ENTX | $2.07 -6.76% -7.25% 1.2K
|
Health Technology
|
| O: 0.82%
H: 5.26%
C: 4.88%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: 0.01%
H: 0.25%
C: -0.98%
presentation phase 2 osteoporosis eb613
Entera Bio to Present Phase 2 EB613 Oral PTH Osteoporosis Treatment 3-Month Findings at the American Society for Bone and Mineral Research Annual Meeting
Published: 2021-08-02 (Crawled : 13:15) - biospace.com/
ENTX | $2.07 -6.76% -7.25% 1.2K
|
Health Technology
|
| O: 5.4%
H: 2.66%
C: 1.71%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: -0.37%
H: 0.15%
C: -0.96%
treatment phase 2 bone eb613 research osteoporosis
Entera Bio to Conduct Conference Call on June 30 to Discuss Phase 2 Results for EB613 Positioned to be the First Oral Bone-Building Agent for the Treatment of Osteoporosis
Published: 2021-06-28 (Crawled : 20:00) - globenewswire.com
ENTX | $2.07 -6.76% -7.25% 1.2K
|
Health Technology
|
| O: -0.66%
H: 0.36%
C: -4.15%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: 0.16%
H: 0.3%
C: -0.31%
treatment phase 2 bone phase 2 results results eb613 conference osteoporosis
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 17M
|
TSLA | News | $162.13 12.06% 10.13% 170M
|
Consumer Durables
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.